Molecular Medicine

The Molecular Medicine Residency track within the Categorical Medicine Residency is designed for individuals who are interested in pursuing a career that emphasizes bench research in combination with the practice of medicine. The overarching goal of the program is to train the next generation of transformative laboratory-based physician-scientists.

The Molecular Medicine Residency provides specialized, individualized attention to each participant’s development as a bench scientist while maintaining the same broad and intensive exposure to clinical medicine that is enjoyed by all UCSF categorical internal medicine residents. Admission to the program is accompanied by a guaranteed subspecialty fellowship position within the Department of Medicine, contingent upon satisfactory completion of residency training. Successful applicants demonstrate potential for excellence in both clinical care and laboratory research, and will have completed a successful MD/PhD program or an in-depth research experience of at least one year.

Curriculum

Molecular Medicine Residents receive personal mentoring in selecting their area of research and choosing laboratories that may be of interest to them for training. They also meet regularly as a group for career guidance seminars and for scientific discussions in a relaxed, informal setting, and attend an annual dinner designed to facilitate interaction among members of the Department’s College of Bench Scientists. Dedicated time for scholarly activity is provided during the R2 year (and R3 year, if applicable). During the R2 year, Molecular Medicine Residents travel to the annual 3-day research retreat of the Biomedical Sciences Program in Lake Tahoe, California, where they can learn more about the rich scientific opportunities at UCSF and an have opportunity to fully immerse themselves in basic/translational science. Molecular Medicine Residents also participate in conferences of the UCSF Molecular Medicine Consult Service, which is designed to promote scientific inquiry among all residents. This service endeavors to apply state-of-the-art tools toward a better understanding of the molecular pathophysiology of disease. Historically, the majority of Molecular Medicine Residents have, pending approval from the Categorical Residency Program Director, opted to short-track into the ABIM Research Pathway.

Current Molecular Medicine Residents

Year	Name and Degree(s)	Degree Granting Institution
R3 2017	Kelly Fitzgerald, MD	University of California, Irvine
R3 2017	Meghan Jobson, MD PhD	University of North Carolina
R3 2017	Lowell Nicholson, MD	Duke University
R3 2017	Noa Simchoni, MD PhD	Icahn School of Medicine at Mt Sinai
R3 2017	Noah Younger, MD PhD	University of California, San Francisco
R2 2018	Christina Homer, MD PhD	University of California, San Francisco
R2 2018	Sarah Hsu, MD PhD	University of Pennsylvania
R2 2018	John Huizar, MD	University of California, San Francisco
R2 2018	Jerry Lee, MD	Duke University
R2 2018	Worawan Limpitikul, MD PhD	Johns Hopkins University
R2 2018	T. Richard Parenteau, MD PhD	University of California, San Francisco
R2 2018	Natasha Spottiswoode, MD PhD	Columbia University
R2 2018	Joshua Schoenfeld, MD PhD	University of Iowa
R2 2018	Travis Zack, MD PhD	Harvard University
R1 2019	Ryan Chang, MD PhD	University of California, San Francisco
R1 2019	Mai Dao, MD	Harvard University
R1 2019	Charlotte Hurabielle-Claverie, MD PhD	Faculte de Medecine Paris Descartes
R1 2019	Anjali Jacob, MD PhD	Boston University
R1 2019	Matthew Jones, MD PhD	University of Chicago
R1 2019	Vipul Kumar, MD PhD	Harvard University
R1 2019	Quinlan Siervers, MD PhD	Harvard University
R1 2019	Jeremiah Wala, MD PhD	Harvard University
R1 2019	Robert Weber, MD PhD	University of California, San Francisco
R1 2019	Andrew Lechner, MD PhD	University of California, San Francisco

Recent Participants

Degree Granting Institution	Name	Subspecialty
2014 Harvard	Vincent Auyeung, MD, PhD	Pulmonary Disease and Critical Care Medicine, UCSF
2014 UCSF	Alan Baik, MD	Cardiology, UCSF
2014 UCSF	Jonathan Chou, MD, PhD	Hematology and Oncology, UCSF
2014 University of Washington	Joseph Hiatt, MD, PhD	Hematology and Oncology, University of Washington
2015 University of Pennsylvania	Chukwuka Didigu, MD, PhD	Hematology and Oncology, UCSF
2015 Harvard	Laura Huppert, MD,	Hematology and Oncology, UCSF
2015 Washington University	Hailyn Nielsen, MD, PhD	Rheumatology, UCSF
2015 University of Chicago	Vaibhav Upadhyay, MD, PhD	Pulmonary Disease and Critical Care Medicine, UCSF
2016 Yale	Nancy Allen, MD, PhD	Pulmonary Disease and Critical Care Medicine, UCSF
2016 Columbia	Stewart Cao, MD, PhD	Gastroenterology, Washington University, St. Louis
2016 University of Michigan	Cailin Collins, MD, PhD	Hematology and Oncology, Stanford University
2016 Baylor	Andrew Folick, MD, PhD	Endocrinology, UCSF
2016 Johns Hopkins	Bridget Keenan, MD, PhD	Hematology and Oncology, UCSF
2016 Icahn School of Medicine at Mount Sinai	Arielle Klepper, MD, PhD	Chief Resident, Internal Medicine, UCSF
2016 Pennsylvania State University College of Medicine	Michelle Matzko, MD, PhD	Infectious Diseases, MGH/BWH
2016 UCSF	Alex Mohapatra, MD, PhD	Pulmonary Disease and Critical Care Medicine, UCSF
2016 Baylor	Kapil Saxena, MD	Hematology and Oncology, MDACC
2017 New York University	Adam Blaisdell, MD, PhD	Gastroenterology, UCSF
2017 Univeristy of Pittsburgh	John Demko, MD	Nephrology, UCSF
2017 Yale	Brendan Huang, MD, PhD	Pulmonary Disease and Critical Care Medicine, UCLA
2017 Cornell	Corynn Kasap, MD, PhD	Hematology and Oncology, UCSF
2017 Cornell	Maxime Kinet, MD, PhD	Rheumatology, UCSF

Application Logistics

Upon receipt of the electronic Residency Application from ERAS, the Residency Admissions Committee selects applicants for interview at UCSF. Applicants invited for an interview are then asked if they wish to be considered for the Molecular Medicine Residency. A separate selection committee reviews applicants and issues invitations to remain an extra day after the Categorical Residency application day to interview specifically for the Molecular Medicine Residency.

As stated above, acceptance into the Molecular Medicine Residency includes a commitment of a fellowship position in a specialty of choice. A Molecular Medicine Residency participant, however, may also choose not to specify a particular specialty and, instead, wait to apply after exploring different opportunities during residency.

The UCSF Molecular Medicine Residency Program is fully committed to enhancing diversity at UCSF.
Applications from women and under-represented ethnic/cultural groups are strongly encouraged.

Neil P. Shah, MD PhD
Director, UCSF Molecular Medicine Residency Program

 

Contact Us

Additional questions may be addressed to Vivian Robinson.

Vivian Robinson
415-476-3373
[email protected]
 

Thank you for your interest in the UCSF Molecular Medicine Residency Program.